Maurer, Marcus; Giménez Arnau, Anna Maria; Bernstein, Jonathan A.; Chu, Chia-Yu; Danilycheva, Inna; Hide, Michihiro; Makris, Michael; Metz, Martin; Savic, Sinisa; Sitz, Karl; Soong, Weily; Staubach, Petra; Sussman, Gordon; Barve, Avantika; Burciu, Alis; Hua, Eva; Janocha, Reinhold; Severin, Thomas
(Wiley, 2022)
Background: Ligelizumab, a next-generation, humanized anti-immunoglobulin E (IgE) monoclonal antibody is in development as a treatment for patients with chronic spontaneous urticaria, whose symptoms are inadequately ...